Astellas To Add 300 To China Sales Staff As Part Of Five-Year Growth Plan
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma says it plans to add at least 300 people to its sales staff in China as part of its five-year plan for added global revenues